Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Finished Goods: 2024

Historic Finished Goods for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $873,000.

  • Day One Biopharmaceuticals' Finished Goods was N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $873,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Day One Biopharmaceuticals' Finished Goods stood at $873,000.
  • Day One Biopharmaceuticals' 5-year Finished Goods high stood at $873,000 for FY2024, and its period low was $873,000 during FY2024.
  • Moreover, its 1-year median value for Finished Goods was $873,000 (2024), whereas its average is $873,000.